Literature DB >> 18448526

Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis.

Christophe Le Clorennec1, Tan-Sothéa Ouk, Ibtissam Youlyouz-Marfak, Stéphanie Panteix, Catherine-Claude Martin, Julia Rastelli, Eric Adriaenssens, Ursula Zimber-Strobl, Jean Coll, Jean Feuillard, Chantal Jayat-Vignoles.   

Abstract

The Epstein-Barr virus (EBV) oncoprotein latent membrane protein 1 (LMP1) is thought to act as the major transforming protein in various cell types, by rerouting the tumor necrosis factor receptor family signaling pathway. Despite this implication in EBV-associated transformation of cells, LMP1 toxicity is a well-known but poorly studied feature, perhaps because it contradicts its role in transformation. We show that LMP1 physiological levels are very heterogeneous and that the highest levels of LMP1 correlate with Fas overexpression and spontaneous apoptosis in lymphoblastoid cell lines (LCLs). To understand the cytotoxic effect of LMP1 in LCLs, we cloned wild-type LMP1 into a doxycycline double-inducible episomal vector pRT-1, with a truncated version of NGFR as a surrogate marker of inducibility. We found that LMP1 overexpression induced apoptosis in LCL B cells, as shown by annexin V labeling, sub-G(1) peak, and poly(ADP ribose) polymerase cleavage. Knocking down Fas expression by small interfering RNA abolished LMP1-induced apoptosis. The absence of detectable levels of Fas ligand mRNA suggested a ligand-independent activation of Fas. LMP1 induced Fas overexpression with its relocalization in lipid raft microdomains of the membrane. Fas immunoprecipitation detected FADD (Fas-associated death domain protein) and caspase 8, suggesting a Fas-dependent formation of the death-inducing signaling complex. Caspases 8, 9, 3, and 7 were activated by LMP1. Caspase 8 activation was associated with BID cleavage and truncated-BID mitochondrial relocalization, consistent with type II apoptosis. Therefore, our results are in agreement with a model where LMP1-dependent NF-kappaB activation induces Fas overexpression and autoactivation that could overwhelm the antiapoptotic effect of NF-kappaB, revealing an ambivalent function of LMP1 in cell survival and programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448526      PMCID: PMC2447067          DOI: 10.1128/JVI.02250-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Sensitive and reliable JC-1 and TOTO-3 double staining to assess mitochondrial transmembrane potential and plasma membrane integrity: interest for cell death investigations.

Authors:  Thomas Zuliani; Raphaël Duval; Chantal Jayat; Sylviane Schnébert; Patrice André; Marc Dumas; Marie-Hélène Ratinaud
Journal:  Cytometry A       Date:  2003-08       Impact factor: 4.355

Review 2.  Epstein-Barr virus latent membrane protein 1: structure and functions.

Authors:  Hsin-Pai Li; Yu-Sun Chang
Journal:  J Biomed Sci       Date:  2003 Sep-Oct       Impact factor: 8.410

3.  Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

Authors:  Francesca Cerimele; Traci Battle; Rebecca Lynch; David A Frank; Emma Murad; Cynthia Cohen; Nada Macaron; John Sixbey; Kenneth Smith; Randolph S Watnick; Aristidis Eliopoulos; Bahig Shehata; Jack L Arbiser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

4.  Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

Authors:  O Micheau; E Solary; A Hammann; M T Dimanche-Boitrel
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

5.  The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes.

Authors:  L K Busch; G A Bishop
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

6.  Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells.

Authors:  Peter K M Kim; Sang-Youel Park; Patrick P Koty; Yun Hua; James D Luketich; Timothy R Billiar
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

Review 7.  Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

Authors:  Upasna Gaur; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2003-10-15       Impact factor: 5.858

8.  Ceramide-mediated clustering is required for CD95-DISC formation.

Authors:  Heike Grassmé; Aida Cremesti; Richard Kolesnick; Erich Gulbins
Journal:  Oncogene       Date:  2003-08-21       Impact factor: 9.867

9.  Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation.

Authors:  Xiangning Zhang; Wanlaya Uthaisang; Lifu Hu; Ingemar T Ernberg; Bengt Fadeel
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

10.  DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation.

Authors:  Huey-Lan Huang; Li-Wen Fang; Shu-Ping Lu; Chen-Kung Chou; Tien-Yau Luh; Ming-Zong Lai
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

View more
  28 in total

1.  Soluble factors produced by activated CD4+ T cells modulate EBV latency.

Authors:  Noémi Nagy; Mónika Adori; Abu Rasul; Frank Heuts; Daniel Salamon; Dorina Ujvári; Harsha S Madapura; Benjamin Leveau; George Klein; Eva Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells.

Authors:  A Chanut; F Duguet; A Marfak; A David; B Petit; M Parrens; S Durand-Panteix; M Boulin-Deveza; N Gachard; I Youlyouz-Marfak; D Bordessoule; J Feuillard; N Faumont
Journal:  Leukemia       Date:  2013-09-23       Impact factor: 11.528

3.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 4.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

5.  Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation.

Authors:  Ahmed K M Ali; Satoru Saito; Sachiko Shibata; Kenzo Takada; Teru Kanda
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

6.  An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.

Authors:  Shi-Dong Ma; Xianming Yu; Janet E Mertz; Jenny E Gumperz; Erik Reinheim; Ying Zhou; Weihua Tang; William J Burlingham; Margaret L Gulley; Shannon C Kenney
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

7.  LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Authors:  Shi-Dong Ma; Xuequn Xu; Julie Plowshay; Erik A Ranheim; William J Burlingham; Jeffrey L Jensen; Fotis Asimakopoulos; Weihua Tang; Margaret L Gulley; Ethel Cesarman; Jenny E Gumperz; Shannon C Kenney
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

8.  Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.

Authors:  X Chen; S A Kamranvar; M G Masucci
Journal:  Oncogene       Date:  2015-11-23       Impact factor: 9.867

9.  c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Authors:  Nathalie Faumont; Stéphanie Durand-Panteix; Martin Schlee; Sebastian Grömminger; Marino Schuhmacher; Michael Hölzel; Gerhard Laux; Reinhard Mailhammer; Andreas Rosenwald; Louis M Staudt; Georg W Bornkamm; Jean Feuillard
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

10.  The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.

Authors:  Mujeeb R Cheerathodi; David G Meckes
Journal:  Future Virol       Date:  2018-12-03       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.